ABBOTT LABORATORIES (ABL.DE) Fundamental Analysis & Valuation
FRA:ABL • US0028241000
Current stock price
95.44 EUR
+1.02 (+1.08%)
Last:
This ABL.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. ABL.DE Profitability Analysis
1.1 Basic Checks
- In the past year ABL was profitable.
- In the past year ABL had a positive cash flow from operations.
- Each year in the past 5 years ABL has been profitable.
- In the past 5 years ABL always reported a positive cash flow from operatings.
1.2 Ratios
- ABL has a better Return On Assets (7.52%) than 87.30% of its industry peers.
- With a decent Return On Equity value of 12.51%, ABL is doing good in the industry, outperforming 79.37% of the companies in the same industry.
- ABL has a better Return On Invested Capital (9.17%) than 76.19% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for ABL is in line with the industry average of 9.72%.
- The last Return On Invested Capital (9.17%) for ABL is above the 3 year average (8.63%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.52% | ||
| ROE | 12.51% | ||
| ROIC | 9.17% |
ROA(3y)10.6%
ROA(5y)10.1%
ROE(3y)18.49%
ROE(5y)18.82%
ROIC(3y)8.63%
ROIC(5y)9.58%
1.3 Margins
- With an excellent Profit Margin value of 14.72%, ABL belongs to the best of the industry, outperforming 90.48% of the companies in the same industry.
- ABL's Profit Margin has improved in the last couple of years.
- ABL has a Operating Margin of 18.85%. This is in the better half of the industry: ABL outperforms 77.78% of its industry peers.
- ABL's Operating Margin has improved in the last couple of years.
- ABL's Gross Margin of 56.68% is in line compared to the rest of the industry. ABL outperforms 50.79% of its industry peers.
- In the last couple of years the Gross Margin of ABL has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.85% | ||
| PM (TTM) | 14.72% | ||
| GM | 56.68% |
OM growth 3Y-1.98%
OM growth 5Y3.67%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.22%
GM growth 5Y-0.03%
2. ABL.DE Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ABL is destroying value.
- The number of shares outstanding for ABL has been increased compared to 1 year ago.
- ABL has less shares outstanding than it did 5 years ago.
- Compared to 1 year ago, ABL has an improved debt to assets ratio.
2.2 Solvency
- An Altman-Z score of 5.04 indicates that ABL is not in any danger for bankruptcy at the moment.
- With an excellent Altman-Z score value of 5.04, ABL belongs to the best of the industry, outperforming 87.30% of the companies in the same industry.
- ABL has a debt to FCF ratio of 1.75. This is a very positive value and a sign of high solvency as it would only need 1.75 years to pay back of all of its debts.
- With an excellent Debt to FCF ratio value of 1.75, ABL belongs to the best of the industry, outperforming 82.54% of the companies in the same industry.
- ABL has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
- With a decent Debt to Equity ratio value of 0.19, ABL is doing good in the industry, outperforming 74.60% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | 1.75 | ||
| Altman-Z | 5.04 |
ROIC/WACC0.92
WACC9.92%
2.3 Liquidity
- ABL has a Current Ratio of 1.58. This is a normal value and indicates that ABL is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Current ratio, with a value of 1.58, ABL is in line with its industry, outperforming 47.62% of the companies in the same industry.
- ABL has a Quick Ratio of 1.18. This is a normal value and indicates that ABL is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 1.18, ABL is in line with its industry, outperforming 50.79% of the companies in the same industry.
- ABL does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.58 | ||
| Quick Ratio | 1.18 |
3. ABL.DE Growth Analysis
3.1 Past
- ABL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.28%, which is quite good.
- ABL shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.13% yearly.
- ABL shows a small growth in Revenue. In the last year, the Revenue has grown by 5.67%.
- Measured over the past years, ABL shows a small growth in Revenue. The Revenue has been growing by 5.08% on average per year.
EPS 1Y (TTM)10.28%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%11.94%
Revenue 1Y (TTM)5.67%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%4.42%
3.2 Future
- ABL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.38% yearly.
- The Revenue is expected to grow by 7.06% on average over the next years.
EPS Next Y11.53%
EPS Next 2Y10.76%
EPS Next 3Y10.34%
EPS Next 5Y10.38%
Revenue Next Year7%
Revenue Next 2Y7.19%
Revenue Next 3Y7.11%
Revenue Next 5Y7.06%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. ABL.DE Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 21.30, which indicates a rather expensive current valuation of ABL.
- Based on the Price/Earnings ratio, ABL is valued a bit cheaper than the industry average as 69.84% of the companies are valued more expensively.
- ABL is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 25.79, which is the current average of the S&P500 Index.
- ABL is valuated rather expensively with a Price/Forward Earnings ratio of 19.11.
- The rest of the industry has a similar Price/Forward Earnings ratio as ABL.
- ABL is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.80, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.3 | ||
| Fwd PE | 19.11 |
4.2 Price Multiples
- The rest of the industry has a similar Enterprise Value to EBITDA ratio as ABL.
- The rest of the industry has a similar Price/Free Cash Flow ratio as ABL.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 25.79 | ||
| EV/EBITDA | 16.76 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ABL does not grow enough to justify the current Price/Earnings ratio.
- The excellent profitability rating of ABL may justify a higher PE ratio.
PEG (NY)1.85
PEG (5Y)2.99
EPS Next 2Y10.76%
EPS Next 3Y10.34%
5. ABL.DE Dividend Analysis
5.1 Amount
- With a Yearly Dividend Yield of 2.33%, ABL has a reasonable but not impressive dividend return.
- Compared to an average industry Dividend Yield of 1.11, ABL pays a bit more dividend than its industry peers.
- Compared to an average S&P500 Dividend Yield of 1.91, ABL pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.33% |
5.2 History
- The dividend of ABL is nicely growing with an annual growth rate of 10.37%!
Dividend Growth(5Y)10.37%
Div Incr Years6
Div Non Decr Years6
5.3 Sustainability
- 63.09% of the earnings are spent on dividend by ABL. This is not a sustainable payout ratio.
- ABL's earnings are growing around the same pace than its dividend. As long as the earnings growth is kept the dividend growth is sustainable.
DP63.09%
EPS Next 2Y10.76%
EPS Next 3Y10.34%
ABL.DE Fundamentals: All Metrics, Ratios and Statistics
FRA:ABL (3/19/2026, 2:34:46 PM)
95.44
+1.02 (+1.08%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-22 2026-01-22/bmo
Earnings (Next)04-14 2026-04-14/bmo
Inst Owners81.83%
Inst Owner ChangeN/A
Ins Owners0.47%
Ins Owner ChangeN/A
Market Cap165.84B
Revenue(TTM)44.33B
Net Income(TTM)6.52B
Analysts80
Price Target114.26 (19.72%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.33% |
Yearly Dividend2.07
Dividend Growth(5Y)10.37%
DP63.09%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.9%
Min EPS beat(2)-1.06%
Max EPS beat(2)-0.75%
EPS beat(4)1
Avg EPS beat(4)-0.41%
Min EPS beat(4)-1.06%
Max EPS beat(4)0.73%
EPS beat(8)3
Avg EPS beat(8)0.09%
EPS beat(12)6
Avg EPS beat(12)0.64%
EPS beat(16)10
Avg EPS beat(16)5.12%
Revenue beat(2)0
Avg Revenue beat(2)-2.58%
Min Revenue beat(2)-3.88%
Max Revenue beat(2)-1.29%
Revenue beat(4)0
Avg Revenue beat(4)-1.72%
Min Revenue beat(4)-3.88%
Max Revenue beat(4)-0.33%
Revenue beat(8)0
Avg Revenue beat(8)-1.18%
Revenue beat(12)3
Avg Revenue beat(12)-0.45%
Revenue beat(16)7
Avg Revenue beat(16)1.23%
PT rev (1m)-1.45%
PT rev (3m)-8.45%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.33%
EPS NY rev (1m)0.03%
EPS NY rev (3m)0.2%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)-1.98%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.88%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.3 | ||
| Fwd PE | 19.11 | ||
| P/S | 4.3 | ||
| P/FCF | 25.79 | ||
| P/OCF | 19.94 | ||
| P/B | 3.66 | ||
| P/tB | 8.45 | ||
| EV/EBITDA | 16.76 |
EPS(TTM)4.48
EY4.69%
EPS(NY)4.99
Fwd EY5.23%
FCF(TTM)3.7
FCFY3.88%
OCF(TTM)4.79
OCFY5.02%
SpS22.18
BVpS26.09
TBVpS11.29
PEG (NY)1.85
PEG (5Y)2.99
Graham Number51.28
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.52% | ||
| ROE | 12.51% | ||
| ROCE | 11.9% | ||
| ROIC | 9.17% | ||
| ROICexc | 10.51% | ||
| ROICexgc | 20.3% | ||
| OM | 18.85% | ||
| PM (TTM) | 14.72% | ||
| GM | 56.68% | ||
| FCFM | 16.68% |
ROA(3y)10.6%
ROA(5y)10.1%
ROE(3y)18.49%
ROE(5y)18.82%
ROIC(3y)8.63%
ROIC(5y)9.58%
ROICexc(3y)9.83%
ROICexc(5y)11.21%
ROICexgc(3y)21.64%
ROICexgc(5y)29.96%
ROCE(3y)11.19%
ROCE(5y)12.44%
ROICexgc growth 3Y-22.35%
ROICexgc growth 5Y-6%
ROICexc growth 3Y-8.69%
ROICexc growth 5Y6.09%
OM growth 3Y-1.98%
OM growth 5Y3.67%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.22%
GM growth 5Y-0.03%
F-Score6
Asset Turnover0.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | 1.75 | ||
| Debt/EBITDA | 0.86 | ||
| Cap/Depr | 69.67% | ||
| Cap/Sales | 4.9% | ||
| Interest Coverage | 15.33 | ||
| Cash Conversion | 83.39% | ||
| Profit Quality | 113.35% | ||
| Current Ratio | 1.58 | ||
| Quick Ratio | 1.18 | ||
| Altman-Z | 5.04 |
F-Score6
WACC9.92%
ROIC/WACC0.92
Cap/Depr(3y)68.72%
Cap/Depr(5y)62.77%
Cap/Sales(3y)5.22%
Cap/Sales(5y)4.82%
Profit Quality(3y)83.05%
Profit Quality(5y)96.8%
High Growth Momentum
Growth
EPS 1Y (TTM)10.28%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%11.94%
EPS Next Y11.53%
EPS Next 2Y10.76%
EPS Next 3Y10.34%
EPS Next 5Y10.38%
Revenue 1Y (TTM)5.67%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%4.42%
Revenue Next Year7%
Revenue Next 2Y7.19%
Revenue Next 3Y7.11%
Revenue Next 5Y7.06%
EBIT growth 1Y18.75%
EBIT growth 3Y-1.48%
EBIT growth 5Y8.93%
EBIT Next Year25.72%
EBIT Next 3Y14.17%
EBIT Next 5Y13.17%
FCF growth 1Y16.44%
FCF growth 3Y-1.78%
FCF growth 5Y5.26%
OCF growth 1Y11.78%
OCF growth 3Y-0.05%
OCF growth 5Y3.9%
ABBOTT LABORATORIES / ABL.DE Fundamental Analysis FAQ
What is the fundamental rating for ABL stock?
ChartMill assigns a fundamental rating of 6 / 10 to ABL.DE.
Can you provide the valuation status for ABBOTT LABORATORIES?
ChartMill assigns a valuation rating of 3 / 10 to ABBOTT LABORATORIES (ABL.DE). This can be considered as Overvalued.
What is the profitability of ABL stock?
ABBOTT LABORATORIES (ABL.DE) has a profitability rating of 8 / 10.
Can you provide the PE and PB ratios for ABL stock?
The Price/Earnings (PE) ratio for ABBOTT LABORATORIES (ABL.DE) is 21.3 and the Price/Book (PB) ratio is 3.66.
How sustainable is the dividend of ABBOTT LABORATORIES (ABL.DE) stock?
The dividend rating of ABBOTT LABORATORIES (ABL.DE) is 5 / 10 and the dividend payout ratio is 63.09%.